Skip to main content
. Author manuscript; available in PMC: 2021 Apr 15.
Published in final edited form as: Cell Rep. 2021 Mar 16;34(11):108869. doi: 10.1016/j.celrep.2021.108869

Figure 2. Deletion of SFXN1 alone does not disrupt iron metabolism.

Figure 2.

(A) Cell viability of HEK293 WT and SFXN1 KOs upon treatment with the indicated concentration of the iron chelator deferoxamine mesylate (DFO) for 24 h (mean ± SEM, n = 3).

(B and C) Relative metal concentrations in WT and SFXN1 KO cells (B) and mitochondria (C), as determined by ICP-MS (mean ± SEM, n = 3).

*p < 0.05; unpaired Student’s t test.